P2‐309: Correction of ApoE4 dysfunction and reversal of Alzheimer's disease phenotype and cognition in ApoE4 target replacement mice by cogpepb, an abca1 agonist peptide derived from the lipid binding segment of ApoE. (1st July 2015)